US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LakeShore Biopharma Co., Ltd.

1.40

+0.12009.38%

Post-market: 1.400.00000.00%16:05 EDT

Volume:5.78K

Turnover:7.79K

Market Cap:26.71M

PE:-0.25

High:1.40

Open:1.36

Low:1.30

Close:1.28

Loading ...

Overview Company News Filings

Deutsche Bank Lifts Price Target on LSB Industries to $10 From $9, Keeps Buy Rating

MT Newswires Live

LSB Industries Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

LSB Industries Inc (LXU) Q3 2024 Earnings Call Highlights: Strategic Turnaround and Expansion ...

LSB Industries Inc reports results for the quarter ended in September 30 - Earnings Summary

LSB: Q3 Earnings Snapshot

Associated Press Finance

LSB Industries Q3 2024 Adj. EPS $(0.11) Misses $(0.07) Estimate, Sales $109.217M Beat $95.860M Estimate

LSB Industries reports Q3 EPS (35c), consensus (7c)

BRIEF-LSB Industries Q3 Sales USD 109.217 Million

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Rule; Shares Rise

MT Newswires Live

Legal watchdog slammed for failing to handle Axiom Ince collapse

LakeShore Biopharma Achieves Nasdaq Compliance Milestone

LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

LSB Industries Inc expected to post a loss of 7 cents a share - Earnings Preview

LakeShore Biopharma Gets China Approval for Phase 3 Trial of New Rabies Vaccine Regimen

MT Newswires Live

LakeShore Biopharma Advances with Rabies Vaccine Trial

LakeShore’s YSJA rabies vaccine receives approval for Phase III trial in China

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LSB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LSB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LSB\",,,,,undefined,":{"symbol":"LSB","market":"US","secType":"STK","nameCN":"LakeShore Biopharma Co., Ltd.","latestPrice":1.4,"timestamp":1745352000000,"preClose":1.28,"halted":0,"volume":5776,"hourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.4,"latestTime":"16:05 EDT","volume":1,"amount":1.35,"timestamp":1745352311533},"delay":0,"floatShares":3598541,"shares":19080751,"eps":-5.614551,"marketStatus":"Closed","change":0.12,"latestTime":"04-22 16:00:00 EDT","open":1.36,"high":1.4,"low":1.30302,"amount":7791.498545,"amplitude":0.075766,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.614551,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.28,"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.4,"latestTime":"16:05 EDT","volume":1,"amount":1.35,"timestamp":1745352311533},"volumeRatio":0.203439},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LSB\",,,,,undefined,":{"symbol":"LSB","floatShares":3598541,"roa":"-13.85%","roe":"-65.99%","lyrEps":-5.614551,"volumeRatio":0.203439,"shares":19080751,"dividePrice":0,"high":1.4,"amplitude":0.075766,"preClose":1.28,"low":1.30302,"week52Low":1.2601,"pbRate":"0.33","psRate":"0.34","week52High":11.2,"institutionHeld":0,"latestPrice":1.4,"eps":-5.614551,"divideRate":0,"volume":5776,"delay":0,"ttmEps":-5.614551,"open":1.36,"prevYearClose":3.46,"prevWeekClose":1.3788,"prevMonthClose":2.45,"prevQuarterClose":2.45,"fiveDayClose":1.76,"twentyDayClose":2.71,"sixtyDayClose":2.62},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LSB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2479707065","title":"Deutsche Bank Lifts Price Target on LSB Industries to $10 From $9, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479707065","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479707065?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:37","pubTimestamp":1730374650,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $8 to $15.(MT Newswires covers equity, commodity and economic r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXU","DB","LSB"],"gpt_icon":0},{"id":"2479706722","title":"LSB Industries Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2479706722","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479706722?lang=en_us&edition=fundamental","pubTime":"2024-10-31 18:20","pubTimestamp":1730370016,"startTime":"0","endTime":"0","summary":"NYSE:LXU Earnings and Revenue Growth October 31st 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 13%. Earnings per share  missed analyst estimates significantly.Looking ahead, revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in the US.The company's shares are down 6.7% from a week ago.Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of LSB Industries' balance sheet and an in-depth analysis of the company's financial position.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-third-quarter-2024-102016663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479722971","title":"LSB Industries Inc (LXU) Q3 2024 Earnings Call Highlights: Strategic Turnaround and Expansion ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722971","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479722971?lang=en_us&edition=fundamental","pubTime":"2024-10-31 15:11","pubTimestamp":1730358696,"startTime":"0","endTime":"0","summary":"Adjusted EBITDA: $17 million, a significant improvement over the previous year.GAAP Loss Per Share: $0.35, including $16 million in turnaround expenses and $6 million in noncash charges.Natural Gas Costs: Averaged approximately $2.60 per MMBTU quarter to date.Ammonia Pricing: Tampa ammonia averaged $560 per metric ton quarter to date.UAN Pricing: Nola UAN around $230 per ton.Turnaround Expenses: Estimated $15 million for the Cherokee facility in Q4 2024.GuruFocus has detected 3 Warning Signs with LXU.For the complete transcript of the earnings call, please refer to the full earnings call transcript.LSB Industries Inc  reported a significant year-over-year improvement in adjusted EBITDA despite undergoing a major turnaround at their Pryor facility.LSB Industries Inc  expanded its Urea plant at Pryor, which is expected to produce an additional 75,000 tons per year of UAN, marking a 20% annual increase.The company completed the construction of additional nitric acid storage at the El Dora","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.R7QdYsGPKINYRpb0ee6ig--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/12fc31bfc1681f20fbfcff3446d0238f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.R7QdYsGPKINYRpb0ee6ig--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/12fc31bfc1681f20fbfcff3446d0238f"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-inc-lxu-q3-071136647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479215114","title":"LSB Industries Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2479215114","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479215114?lang=en_us&edition=fundamental","pubTime":"2024-10-30 11:03","pubTimestamp":1730257392,"startTime":"0","endTime":"0","summary":"* LSB Industries Inc    reported quarterly breakeven results per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -6 cents.  The mean ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2479257380","title":"LSB: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2479257380","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479257380?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:34","pubTimestamp":1730234059,"startTime":"0","endTime":"0","summary":"OKLAHOMA CITY  — OKLAHOMA CITY  — LSB Industries Inc.  on Tuesday reported a loss of $25.4 million in its third quarter.The Oklahoma City-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, were 11 cents per share.The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.The chemical maker posted revenue of $109.2 million in the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-q3-earnings-snapshot-203419993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2479325420","title":"LSB Industries Q3 2024 Adj. EPS $(0.11) Misses $(0.07) Estimate, Sales $109.217M Beat $95.860M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2479325420","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479325420?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:28","pubTimestamp":1730233728,"startTime":"0","endTime":"0","summary":"LSB Industries (NYSE:LXU) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent.  The company reported quarterly sales of $109.217 million which beat the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41611489/lsb-industries-q3-2024-adj-eps-0-11-misses-0-07-estimate-sales-109-217m-beat-95-860m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2479252858","title":"LSB Industries reports Q3 EPS (35c), consensus (7c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479252858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479252858?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:22","pubTimestamp":1730233327,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $109.2M, consensus $95.86M. The third quarter 2024 diluted EPS included approximately (24c) per share of turnaround costs and on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-35c-consensus-7c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lsb-industries-reports-q3-eps-35c-consensus-7c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB"],"gpt_icon":0},{"id":"2479251116","title":"BRIEF-LSB Industries Q3 Sales USD 109.217 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479251116","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479251116?lang=en_us&edition=fundamental","pubTime":"2024-10-30 04:10","pubTimestamp":1730232646,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - LSB Industries Q3 net income USD -25.382 million. * Q3 operating income USD -24.423 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXU","USD","LSB"],"gpt_icon":0},{"id":"2479814052","title":"LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Rule; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2479814052","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479814052?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:39","pubTimestamp":1730212751,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma  said Tuesday the Nasdaq Stock Market notified the company Oct. 21 that it was in compliance with the exchange's minimum bid price requirement for continued listing.The company regained compliance after the closing bid price of its shares was at $1 each or higher for 11 consecutive business days through Oct. 18.LakeShore shares were up 3.5% in recent trading.Price: 2.97, Change: +0.10, Percent Change: +3.48","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2095319765.USD","LU2210149790.SGD","LSB","NDAQ","NQmain","BK4139","BK4112","IE00BKPKM429.USD","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","IE00B64PRP62.GBP",".IXIC","LU2210150020.SGD"],"gpt_icon":0},{"id":"2479228932","title":"Legal watchdog slammed for failing to handle Axiom Ince collapse","url":"https://stock-news.laohu8.com/highlight/detail?id=2479228932","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479228932?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:13","pubTimestamp":1730211181,"startTime":"0","endTime":"0","summary":"The law firm became engulfed in a scandal last year after it emerged that approximately 60m in client money had gone missing.  The UK’s legal regulator has been slammed for mishandling the collapse of Axiom Ince, which resulted in over 1,000 job losses. The law firm became engulfed in a scandal last year after it emerged that approximately 60m in client money had gone missing. Not long after, the firm folded and 1,400 employees lost their jobs.  Senior management at the firm are now being investigated by the Serious Fraud Office for suspected fraud. In a scathing report published today, the Solicitor’s Regulation Authority  was found to have not taken enough steps to help prevent the firm’s collapse.“At the heart of this issue is a suspected complex and well-hidden fraud carried out by a solicitor, with an ongoing criminal investigation by the SFO,” he said. “We will be consulting soon on changes to better protect clients’ money. This will include exploring the more radical solution of","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/05/legal-1200-x-800-1.jpeg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/05/legal-1200-x-800-1.jpeg?w=286&h=161&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/legal-watchdog-slammed-for-failing-to-handle-axiom-ince-collapse/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2479909283","title":"LakeShore Biopharma Achieves Nasdaq Compliance Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2479909283","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479909283?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:48","pubTimestamp":1730209711,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has successfully regained compliance with Nasdaq’s minimum bid price requirem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-achieves-nasdaq-compliance-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-achieves-nasdaq-compliance-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","BK4139","MNQmain","SQQQ","LSB","BK4112",".IXIC","QID","BK4588","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","LU2095319765.USD","BK4585","LU2210149790.SGD","QLD","PSQ","TQQQ","LU2210150020.SGD","IE00BGHQF748.EUR","NQmain"],"gpt_icon":0},{"id":"2479404287","title":"LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479404287","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479404287?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:46","pubTimestamp":1730205980,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has received a written notice from the Nasdaq Listing Qualifications Department informing the company that it has regaine...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-regains-ompliance-with-nasdaq-minimum-bid-price-requirement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeshore-biopharma-regains-ompliance-with-nasdaq-minimum-bid-price-requirement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","QID","SQQQ","NDAQ","LU2210149790.SGD","BK4585","MNQmain","BK4139","IE00BKPKM429.USD","TQQQ","BK4588","BK4112","LU2095319765.USD","QLD","LU2210150020.SGD","PSQ","LTBR","LSB","IE00B3QW5Z07.USD","NQmain",".IXIC","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2479046674","title":"LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479046674","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479046674?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:30","pubTimestamp":1730205000,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ --LakeShore Biopharma Co., Ltd  , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a written notice  from the Listing Qualifications Department of The Nasdaq Stock Market LLC  dated October 21, 2024, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5550 .As previously announced, the Company was notified by Nasdaq on October 24, 2023 that the Company was not in compliance with the Minimum Bid Price Requirement as the closing bid price of the Company's ordinary shares was below $1.00 per share for a period of 30 consecutive business days.According to the Compliance Notice, the Company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the Com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lakeshore-biopharma-regains-compliance-nasdaq-123000934.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-regains-compliance-nasdaq-123000934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKPKM429.USD","LU2095319765.USD","SQQQ","BK4112","LSB","IE00B3QW5Z07.USD","NQmain","BK4139","IE00B64PRP62.GBP","QLD","QID","MNQmain","LU2210150020.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","TQQQ","BK4588","BK4585","PSQ","LSBPW",".IXIC","NDAQ"],"gpt_icon":1},{"id":"2478920792","title":"LSB Industries Inc    expected to post a loss of 7 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2478920792","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478920792?lang=en_us&edition=fundamental","pubTime":"2024-10-26 22:47","pubTimestamp":1729954043,"startTime":"0","endTime":"0","summary":"* LSB Industries Inc     is expected to show a fall in quarterly revenue when it reports  results on October 29 for the period ending September 30 2024   * The Oklahoma City Oklahoma-based  company is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSB","LXU"],"gpt_icon":0},{"id":"2478939939","title":"LakeShore Biopharma Gets China Approval for Phase 3 Trial of New Rabies Vaccine Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2478939939","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478939939?lang=en_us&edition=fundamental","pubTime":"2024-10-25 21:39","pubTimestamp":1729863556,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma  said Friday that it has been granted approval by China's National Medical Products Administration for a phase 3 clinical study of a simplified four-dose regimen for its YSJA rabies vaccine.The biopharmaceutical company said the study will begin in December and will evaluate the immunogenicity and safety of its YSJA rabies vaccine across two four-dose immunization schedules compared with the existing five-dose Essen regimen.Shares of LakeShore Biopharma were down more than 4% in early trading Friday.Price: 3.0000, Change: -0.14, Percent Change: -4.46","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2478987372","title":"LakeShore Biopharma Advances with Rabies Vaccine Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2478987372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478987372?lang=en_us&edition=fundamental","pubTime":"2024-10-25 21:00","pubTimestamp":1729861251,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has received approval for a Phase III clinical trial in China to test a simpl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-advances-with-rabies-vaccine-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-advances-with-rabies-vaccine-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2478698471","title":"LakeShore’s YSJA rabies vaccine receives approval for Phase III trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2478698471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478698471?lang=en_us&edition=fundamental","pubTime":"2024-10-25 20:35","pubTimestamp":1729859748,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) announced that it has been granted approval for a Phase III clinical trial by the National Medical Products Administratio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeshores-ysja-rabies-vaccine-receives-approval-for-phase-iii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeshores-ysja-rabies-vaccine-receives-approval-for-phase-iii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4134","III","LSB"],"gpt_icon":0},{"id":"2478982651","title":"LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2478982651","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478982651?lang=en_us&edition=fundamental","pubTime":"2024-10-25 20:30","pubTimestamp":1729859400,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Oct. 25, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd  , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has been granted approval for a Phase III clinical trial  by the National Medical Products Administration  in China to explore the immunogenicity and safety of a simplified four-dose regimen for its YSJA rabies vaccine which is the first generation of the Company's rabies vaccine and has sold more than 100M doses since its market approval. This simplified immunization schedule has the potential to provide patients with more immunization options, reduce physician workload, minimize hospital visits, improve patient adherence to vaccination and also reduce the financial burden on patients under comparable immunogenicity, boosting the vaccine's utility and aiding in the prevention of rabies deaths","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lakeshore-biopharma-granted-phase-iii-123000768.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-granted-phase-iii-123000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSBPW","III","LSB","BK4134"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LSB\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"LSB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1734598800000,"name":null,"time":"Pre-Market","dateTimestamp":1734584400000,"actualEps":null},{"market":"US","date":"2024-10-04","symbol":"LSB","defaultRemindTime":1728048600000,"type":"split","dateTimestamp":1728014400000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2024-04-19","symbol":"LSB","fiscalQuarterEnding":"2024/03","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1713499200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2023-08-15","symbol":"LSB","fiscalQuarterEnding":"2023/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1692072000000,"reportTimeType":"post","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LSB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LSB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LSB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LSB","date":"2025-04-21","current":-0.442538,"percent":1,"low":-3.491689,"twenty":-1.73092,"median":-0.927574,"eighty":-0.752086,"high":-0.442538,"avg":-1.262426,"sd":0.690685,"marketCap":26308539},"quantilePoints":[{"date":"2024-05-31","current":-3.379049,"twenty":-3.469161,"median":-3.435369,"eighty":-3.401577,"marketCap":169495163},{"date":"2024-06-07","current":-3.072453,"twenty":-3.371356,"median":-3.135055,"eighty":-3.084613,"marketCap":154052270},{"date":"2024-06-14","current":-2.598966,"twenty":-3.340584,"median":-3.079966,"eighty":-2.710619,"marketCap":130191118},{"date":"2024-06-21","current":-2.202083,"twenty":-3.176161,"median":-2.85567,"eighty":-2.598257,"marketCap":110171856},{"date":"2024-06-28","current":-2.317535,"twenty":-3.128684,"median":-2.710619,"eighty":-2.596131,"marketCap":115821694},{"date":"2024-07-05","current":-2.146949,"twenty":-3.103199,"median":-2.69144,"eighty":-2.317535,"marketCap":107271605},{"date":"2024-07-12","current":-1.730532,"twenty":-3.079966,"median":-2.597194,"eighty":-2.146565,"marketCap":86612028},{"date":"2024-07-15","current":-1.768838,"twenty":-3.078463,"median":-2.595422,"eighty":-2.077807,"marketCap":88570639},{"date":"2024-08-02","current":-1.732471,"twenty":-3.076961,"median":-2.57528,"eighty":-1.925029,"marketCap":86894520},{"date":"2024-08-09","current":-1.558495,"twenty":-2.98574,"median":-2.317535,"eighty":-1.731308,"marketCap":78909414},{"date":"2024-08-16","current":-1.677497,"twenty":-2.79765,"median":-2.174516,"eighty":-1.651616,"marketCap":84935909},{"date":"2024-08-23","current":-1.389499,"twenty":-2.70884,"median":-2.060617,"eighty":-1.551354,"marketCap":84298760},{"date":"2024-08-30","current":-1.381354,"twenty":-2.700279,"median":-1.800484,"eighty":-1.506217,"marketCap":84356002},{"date":"2024-09-06","current":-1.380245,"twenty":-2.67809,"median":-1.731502,"eighty":-1.441353,"marketCap":84356002},{"date":"2024-09-13","current":-1.632664,"twenty":-2.619546,"median":-1.706288,"eighty":-1.424415,"marketCap":99429796},{"date":"2024-09-20","current":-2.31777,"twenty":-2.598257,"median":-1.731502,"eighty":-1.434014,"marketCap":142151599},{"date":"2024-09-27","current":-2.401667,"twenty":-2.587365,"median":-1.83213,"eighty":-1.441353,"marketCap":148486408},{"date":"2024-10-04","current":-2.111024,"twenty":-2.579306,"median":-1.965432,"eighty":-1.447449,"marketCap":130130721},{"date":"2024-10-11","current":-1.187542,"twenty":-2.537379,"median":-1.83213,"eighty":-1.424415,"marketCap":72697661},{"date":"2024-10-18","current":-1.050239,"twenty":-2.461353,"median":-1.731502,"eighty":-1.409156,"marketCap":63920515},{"date":"2024-10-25","current":-0.98403,"twenty":-2.433604,"median":-1.706288,"eighty":-1.384322,"marketCap":59913558},{"date":"2024-10-31","current":-0.808361,"twenty":-2.40239,"median":-1.677497,"eighty":-1.380245,"marketCap":49228337},{"date":"2024-11-08","current":-0.723692,"twenty":-2.401667,"median":-1.638066,"eighty":-1.187542,"marketCap":43885727},{"date":"2024-11-15","current":-0.824737,"twenty":-2.390017,"median":-1.561438,"eighty":-1.050239,"marketCap":49419145},{"date":"2024-11-22","current":-0.818884,"twenty":-2.386542,"median":-1.539953,"eighty":-0.987121,"marketCap":49037530},{"date":"2024-11-29","current":-0.876908,"twenty":-2.378394,"median":-1.518762,"eighty":-0.973622,"marketCap":52472065},{"date":"2024-12-06","current":-0.880345,"twenty":-2.375485,"median":-1.467347,"eighty":-0.920901,"marketCap":52567469},{"date":"2024-12-13","current":-0.812538,"twenty":-2.329269,"median":-1.436661,"eighty":-0.879649,"marketCap":48465107},{"date":"2024-12-20","current":-0.867192,"twenty":-2.317582,"median":-1.420629,"eighty":-0.858802,"marketCap":51518027},{"date":"2024-12-27","current":-1.147816,"twenty":-2.274251,"median":-1.410551,"eighty":-0.863844,"marketCap":68173615},{"date":"2025-01-03","current":-1.15994,"twenty":-2.2375,"median":-1.395073,"eighty":-0.870746,"marketCap":68881511},{"date":"2025-01-10","current":-0.906937,"twenty":-2.220943,"median":-1.385614,"eighty":-0.876243,"marketCap":53616910},{"date":"2025-01-17","current":-0.756856,"twenty":-2.191056,"median":-1.381198,"eighty":-0.868969,"marketCap":44744361},{"date":"2025-01-24","current":-0.747473,"twenty":-2.146949,"median":-1.315063,"eighty":-0.858717,"marketCap":44458149},{"date":"2025-01-31","current":-0.759658,"twenty":-2.146565,"median":-1.192978,"eighty":-0.843442,"marketCap":45412187},{"date":"2025-02-07","current":-0.821323,"twenty":-2.112945,"median":-1.186052,"eighty":-0.834159,"marketCap":48846722},{"date":"2025-02-14","current":-0.773751,"twenty":-2.111024,"median":-1.159967,"eighty":-0.824737,"marketCap":45988426},{"date":"2025-02-21","current":-0.765092,"twenty":-2.111024,"median":-1.147816,"eighty":-0.818717,"marketCap":45709007},{"date":"2025-02-28","current":-0.724216,"twenty":-2.110519,"median":-1.120658,"eighty":-0.808114,"marketCap":43122497},{"date":"2025-03-07","current":-0.697997,"twenty":-2.070572,"median":-1.050239,"eighty":-0.799985,"marketCap":41750591},{"date":"2025-03-14","current":-0.605901,"twenty":-1.908321,"median":-1.028087,"eighty":-0.784477,"marketCap":36253426},{"date":"2025-03-21","current":-0.654025,"twenty":-1.841759,"median":-1.027906,"eighty":-0.77364,"marketCap":39115539},{"date":"2025-03-28","current":-0.799881,"twenty":-1.832631,"median":-0.992187,"eighty":-0.774235,"marketCap":47719050},{"date":"2025-04-04","current":-0.747091,"twenty":-1.781496,"median":-0.98403,"eighty":-0.772991,"marketCap":44475322},{"date":"2025-04-11","current":-0.524787,"twenty":-1.739744,"median":-0.948238,"eighty":-0.764005,"marketCap":31101624},{"date":"2025-04-17","current":-0.481952,"twenty":-1.731308,"median":-0.93521,"eighty":-0.755409,"marketCap":28621126},{"date":"2025-04-21","current":-0.442538,"twenty":-1.73092,"median":-0.927574,"eighty":-0.752086,"marketCap":26308539}],"updateTime":1745339797379}}}